Status:
UNKNOWN
ManagemEnt of Antifungal Drug in Invasive Aspergillosis：a Real-word Study
Lead Sponsor:
Southeast University, China
Conditions:
Invasive Aspergillosis
Eligibility:
All Genders
18+ years
Brief Summary
To assessed the current situation and outcome of critically ill patients with invasive aspergillus infection.
Detailed Description
To assessed the current situation and outcome of critically ill patients with invasive aspergillus infection.
Eligibility Criteria
Inclusion
- Age\>18 year-old
- Diagosed as invasive aspergillus infection
Exclusion
- Pregnant
Key Trial Info
Start Date :
September 25 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 15 2024
Estimated Enrollment :
550 Patients enrolled
Trial Details
Trial ID
NCT06028451
Start Date
September 25 2023
End Date
December 15 2024
Last Update
October 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Southeast University, Zhongda hospital
Nanjing, Jiangsu, China, 210000